Margaret Dillon

Health Technology

Consumer Services

Health Services

Profile

Margaret Dillon worked as a Vice President-Regulatory Affairs at CV Therapeutics, Inc. and as a Director-Regulatory Affairs at Systemix, Inc. She also held positions as an Executive Director-Regulatory Affairs at Connetics Corp.
and an Associate Director-Regulatory Affairs at Schering-Plough Research Institute.
In 2013-2014, she was the SVP-Regulatory Affairs & Quality Assurance at Cellerant Therapeutics, Inc. Dillon received an undergraduate degree from State University of New York at Albany and a doctorate from State University of New York at Buffalo.

Former positions of Margaret Dillon

Companies	Position	End
Connetics Corp. Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA.	General Counsel	-
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	General Counsel	-
Systemix, Inc. Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.	General Counsel	-
Schering-Plough Research Institute Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.	Corporate Officer/Principal	-
Cellerant Therapeutics, Inc. Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA.	General Counsel	-

See the detail of Margaret Dillon's experience

Training of Margaret Dillon

State University of New York at Albany	Undergraduate Degree
State University of New York at Buffalo	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies